Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-06-10
1998-09-29
Kight, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5482686, 5482678, A61K 31415, C07D23506
Patent
active
058146512
ABSTRACT:
This invention relates to 4-substituted catechol diether compounds which are selective inhibitors of phosphodiesterase (PDE) type IV. The compounds of the present invention are useful in inhibiting PDE.sub.IV and in the treatment of AIDS, asthma, bronchitis, chronic obstructive airways disease, psoriasis, allergic rhinitis, dermatitis and other inflammatory diseases. This invention also relates to pharmaceutical compositions comprising the compounds hereof. ##STR1##
REFERENCES:
patent: 5430062 (1995-07-01), Cushman
patent: 5449687 (1995-09-01), Christensen, IV et al.
patent: 5622977 (1997-04-01), Warrellow
Chemical Abstracts, vol. 117:251066, abstract of EP 497564A1, 1992.
Chemical Abstracts, vol. 115, No. 15, 1991, Abs. No. 158680z.
Chemical Abstracts, vol. 112, No. 19, 1990, Abs. No. 172319h.
Beavo, J. A. et al., TiPS, Apr. 1990, vol. 11, pp. 150-155.
Nicholson, C. D. et al., TiPS, Jan. 1991, vol. 12, pp. 19-27.
Sutherland, E. W. et al., Pharmacol. Rev., 1960, 12, pp. 265-299.
Verghese, M. W. et al., J. Mol. Cell Cadiol., 1989, 12 (Suppl. II), S61.
Duplantier Allen Jacob
Eggler James Frederick
Marfat Anthony
Masamune Hiroko
Appleman Jolene W.
Ginsburg Paul H.
Kight John
M. Mach D. Margaret
Pfizer Inc.
LandOfFree
Catechol diethers as selective PDE.sup.IV inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Catechol diethers as selective PDE.sup.IV inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Catechol diethers as selective PDE.sup.IV inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-686677